|
Let’s make Canada a global leader in COVID-19 treatments
Tuesday, November 24th, 2020
Canadian-led breakthroughs in medical sciences can improve our health and well-being, bolster our universities and research hospitals, strengthen our reputation in the global competition for resources and talent, and result in economic benefits for Canadians. And, most importantly, these trials could quickly develop novel therapies for treating COVID-19 while creating the downstream benefits of infrastructure and know-how to help us discover treatments for the next pandemic as well as for other diseases.
Tags: disabilities, Health, jurisdiction, participation, pharmaceutical
Posted in Health Policy Context | No Comments »
Recent Comments